Who are N-Acetyl-Tyrosine's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Nutrestore, Sinemet Cr, Inbrija, Carbidopa Levodopa, L- DOPA, CARBIDOPA AND LEVODOPA.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/n-acetyltyrosine.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

N-Acetyl-Tyrosine — Competitive Intelligence Brief

N-Acetyl-Tyrosine (N-Acetyltyrosine) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Amino Acid [EPC]. Area: Neuroscience.

marketed Amino Acid [EPC] Neuroscience Live · refreshed every 30 min

Target snapshot

N-Acetyl-Tyrosine (N-Acetyltyrosine).

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
N-Acetyl-Tyrosine TARGET	N-Acetyltyrosine		marketed	Amino Acid [EPC]
Nutrestore	GLUTAMINE	Emmaus Medcl	marketed	Amino Acid [EPC]		2004-01-01
Sinemet Cr	CARBIDOPA	Aton	marketed	Aromatic Amino Acid [EPC]	Lysine-specific demethylase 4E	1975-01-01
Inbrija	LEVODOPA	Merz	marketed	Aromatic Amino Acid [EPC]	Tyrosine-protein kinase Fyn	1970-01-01
Carbidopa Levodopa	Carbidopa Levodopa	University of Washington	marketed	Aromatic Amino Acid [EPC]
L- DOPA	L- DOPA	Shaare Zedek Medical Center	marketed	Aromatic Amino Acid [EPC]
CARBIDOPA AND LEVODOPA	CARBIDOPA,LEVODOPA	BIOCON PHARMA LIMITED	marketed	Aromatic Amino Acid [EPC]

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

2029-02-03 — Inbrija · RE43711 · Method of Use · US
2032-11-16 — Inbrija · 8685442 · Formulation · US
2032-11-16 — Inbrija · 8945612 · Formulation · US
2032-11-16 — Inbrija · 8545878 · Formulation · US
2032-11-16 — Inbrija · 9393210 · Formulation · US
2033-10-21 — Inbrija · 12458615 · Method of Use · US

Sponsor landscape (Amino Acid [EPC] class)

· 6 drugs in this class
Emmaus Medcl · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). N-Acetyl-Tyrosine — Competitive Intelligence Brief. https://druglandscape.com/ci/n-acetyltyrosine. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab